Senseonics Holdings (SENS) Cash & Equivalents (2014 - 2026)
Senseonics Holdings' (SENS) quarterly Cash & Equivalents came in at $142.7 million in Q2 2026, up 12.9% year-over-year from $126.4 million in Q2 2025, and up 121.93% quarter-over-quarter from $64.3 million in Q1 2026.
Analysis
Senseonics Holdings (SENS) Cash & Equivalents (2014 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has reported Cash & Equivalents for 13 consecutive years, with $142.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash & Equivalents rose 12.9% year-over-year to $142.7 million in Q2 2026; TTM through Jun 2026 was $142.7 million, a 12.9% increase from a year earlier, with the FY2025 full-year figure at $40.2 million, down 46.06% from the prior year.
- Cash & Equivalents was $142.7 million for Q2 2026 at Senseonics Holdings, up from $64.3 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $166.9 million in Q1 2022 and troughed at $35.8 million in Q4 2022.
- A 5-year average of $103.3 million and a median of $104.8 million in 2024 frame the typical range for Cash & Equivalents.
- Across the five-year window, Cash & Equivalents soared 111.52% in 2023 and sank 46.06% in 2025, its largest moves.
- Over 5 years, Cash & Equivalents stood at $35.8 million in 2022, then jumped by 111.52% to $75.7 million in 2023, then retreated by 1.47% to $74.6 million in 2024, then slumped by 46.06% to $40.2 million in 2025, then soared by 254.68% to $142.7 million in 2026.
- The last three Cash & Equivalents figures came in at $142.7 million (Q2 2026), $64.3 million (Q1 2026), and $40.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 2.76 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.69 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 3.39 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 539.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 2.91 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 1.36 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 1.11 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Senseonics Holdings | 507.86 Mn | 267.25 Mn | 8.56 Mn | 142.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 142.70 Mn |
| Mar 31, 2026 | 64.30 Mn |
| Dec 31, 2025 | 40.23 Mn |
| Sep 30, 2025 | 111.00 Mn |
| Jun 30, 2025 | 126.40 Mn |
| Mar 31, 2025 | 64.20 Mn |
| Dec 31, 2024 | 74.60 Mn |
| Sep 30, 2024 | 74.50 Mn |
| Jun 30, 2024 | 84.60 Mn |
| Mar 31, 2024 | 98.70 Mn |
| Dec 31, 2023 | 75.71 Mn |
| Sep 30, 2023 | 125.40 Mn |
| Jun 30, 2023 | 125.10 Mn |
| Mar 31, 2023 | 136.60 Mn |
| Dec 31, 2022 | 35.79 Mn |
| Sep 30, 2022 | 163.00 Mn |
| Jun 30, 2022 | 150.50 Mn |
| Mar 31, 2022 | 166.90 Mn |
| Dec 31, 2021 | 33.46 Mn |
| Sep 30, 2021 | 201.10 Mn |